16 results  1 of 1 

1 Osteoporotic Fractures of the Spine, Hip, and Other Locations after Adjuvant Endocrine Therapy with Aromatase Inhibitors in Breast Cancer Patients: a Meta-analysis
Young-Kyun Lee, Eun-Gyeong Lee, Ha Young Kim, Youjin Lee, Seung-Mi Lee, Dong-Churl Suh, Jun-Il Yoo, Seeyoun Lee
J Korean Med Sci.2020;35(46):e403.  Published online 2020 November 16     DOI: http://dx.doi.org/10.3346/jkms.2020.35.e403
      
2 Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status
Jihye Choi, Chan Sub Park, Min-Ki Seong, Hyesil Seol, Jae-Sung Kim, In-Chul Park, Woo Chul Noh, Hyun-Ah Kim
J Breast Cancer.2020;23(1):10-19.   Published online 2019 December 31     DOI: http://dx.doi.org/10.4048/jbc.2020.23.e5
      
3 PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression
Peey-Sei Kok, Philip Beale, Rachel L. O'Connell, Peter Grant, Tony Bonaventura, James Scurry, Yoland Antill, Jeffrey Goh, Katrin Sjoquist, Anna DeFazio, Cristina Mapagu, Frederic Amant, Michael Friedlander,
J Gynecol Oncol.2019;30(5):e86.  Published online 2019 April 30     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e86
      
4 A pilot study of gonadotropin-releasing hormone agonist combined with aromatase inhibitor as fertility-sparing treatment in obese patients with endometrial cancer
Zhibo Zhang, Huifang Huang, Fengzhi Feng, Jinhui Wang, Ninghai Cheng
J Gynecol Oncol.2019;30(4):e61.  Published online 2019 February 26     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e61
      
5 Gonadotropin-releasing Hormone Agonist Plus Aromatase Inhibitor in the Treatment of Uterine Leiomyoma in Near Menopause Patient: A Case Series Study
Sanam Moradan
J Menopausal Med.2018;24(1):62-66.   Published online 2018 April 30     DOI: http://dx.doi.org/10.6118/jmm.2018.24.1.62
      
6 The serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Yoo Jin Shim, Aeran Seol, Dayong Lee, Seul Ki Kim, Jung Ryeol Lee, Byung Chul Jee, Chang Suk Suh, Seok Hyun Kim
Obstet Gynecol Sci.2018;61(2):242-246.   Published online 2018 February 28     DOI: http://dx.doi.org/10.5468/ogs.2018.61.2.242
      
7 Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor–Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
Koung Jin Suh, Se Hyun Kim, Kyung-Hun Lee, Tae-Yong Kim, Yu Jung Kim, Sae-Won Han, Eunyoung Kang, Eun-Kyu Kim, Kidong Kim, Jae Hong No, Wonshik Han, Dong-Young Noh, Maria Lee, Hee Seung Kim, Seock-Ah Im, Jee Hyun Kim
Cancer Res Treat.2017;49(4):1153-1163.   Published online 2017 February 27     DOI: http://dx.doi.org/10.4143/crt.2016.463
      
8 Long-term survival of patients with recurrent endometrial stromal sarcoma: a multicenter, observational study
Hiroyuki Yamazaki, Yukiharu Todo, Kenrokuro Mitsube, Hitoshi Hareyama, Chisa Shimada, Hidenori Kato, Katsushige Yamashiro
J Gynecol Oncol.2015;26(3):214-221.   Published online 2015 July 8     DOI: http://dx.doi.org/10.3802/jgo.2015.26.3.214
      
9 Increased Sclerostin Levels after Further Ablation of Remnant Estrogen by Aromatase Inhibitors
Wonjin Kim, Yoonjung Chung, Se Hwa Kim, Sehee Park, Jae Hyun Bae, Gyuri Kim, Su Jin Lee, Jo Eun Kim, Byeong-Woo Park, Sung-Kil Lim, Yumie Rhee
Endocrinol Metab.2015;30(1):58-64.   Published online 2015 March 27     DOI: http://dx.doi.org/10.3803/EnM.2015.30.1.58
      
10 Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors
Sung Gwe Ahn, Sung Hyun Kim, Hak Min Lee, Seung Ah Lee, Joon Jeong
J Breast Cancer.2014;17(4):350-355.   Published online 2014 December 26     DOI: http://dx.doi.org/10.4048/jbc.2014.17.4.350
      
11 Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer
Jin Park, Ju-Ik Kim, Seok-Kweon Yun, Han-Uk Kim, Chull-Wan Ihm
Ann Dermatol.2014;26(6):743-746.   Published online 2014 November 26     DOI: http://dx.doi.org/10.5021/ad.2014.26.6.743
      
12 Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors
Jin Young Park, Se Kyung Lee, Soo Youn Bae, Jiyoung Kim, Min Kuk Kim, Won Ho Kil, Jeong Eon Lee, Seok Jin Nam
J Korean Surg Soc.2013;85(5):205-211.   Published online 2013 October 25     DOI: http://dx.doi.org/10.4174/jkss.2013.85.5.205
   
13 Quality of Life Assessment in Women with Breast Cancer: A Prospective Study Including Hormonal Therapy
Fatma Sert, Zeynep Ozsaran, Erhan Eser, Senem Demirci Alanyalı, Ayfer Haydaroglu, Arif Aras
J Breast Cancer.2013;16(2):220-228.   Published online 2013 June 28     DOI: http://dx.doi.org/10.4048/jbc.2013.16.2.220
      
14 Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
June Koo Lee, Seock-Ah Im, Daewon Lee, Ji-Yeon Kim, Yoojoo Lim, Eunyoung Lee, Hyeong-Gon Moon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Se-Hoon Lee, Wonshik Han, Dong-Wan Kim, Tae-You Kim, Dong-Young Noh
J Breast Cancer.2013;16(1):66-71.   Published online 2013 March 31     DOI: http://dx.doi.org/10.4048/jbc.2013.16.1.66
      
15 Hormonal Changes during Extended Letrozole Treatment after Completion of 5 Years of Tamoxifen in Premenopausal Patients with Breast Cancer who Became Postmenopausal
Ja Young Cho, Hee-Jung Kim, Jong-Won Lee, Jong-Han Yu, Beom-Suk Koh, On Vox Yi, Byung-Ho Son, Sei-Hyun Ahn
J Breast Cancer.2010;13(4):375-381.   Published online 2010 December 31     DOI: http://dx.doi.org/10.4048/jbc.2010.13.4.375
      
16 Adjuvant Hormonal Therapy: Current Standard and Practical Issues
Byeong-Woo Park, Hyung Seok Park
J Breast Cancer.2010;13(3):242-249.   Published online 2010 September 29     DOI: http://dx.doi.org/10.4048/jbc.2010.13.3.242
      

 1 of 1